Cargando…
A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement
RATIONALE: Subcutaneous immunoglobulin administration facilitated by recombinant human hyaluronidase is a new mode of immunoglobulin replacement. It has been approved for treatment in primary and secondary antibody immunodeficiency. To date, it has not been reported in the literature as therapy of c...
Autores principales: | Więsik-Szewczyk, Ewa, Jahnz-Różyk, Karina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221563/ https://www.ncbi.nlm.nih.gov/pubmed/30383634 http://dx.doi.org/10.1097/MD.0000000000012804 |
Ejemplares similares
-
From infections to autoimmunity: Diagnostic challenges in common variable immunodeficiency
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2020) -
Increased Access to Immunoglobulin Replacement Therapy for Patients with Primary Immunodeficiency in Poland Based on Clinical Usage Data of Immunoglobulin G over a 5-Year Period
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2023) -
Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies
por: Wiesik-Szewczyk, Ewa, et al.
Publicado: (2020) -
Patients with Common Variable Immunodeficiency Complicated by Autoimmune Phenomena Have Lymphopenia and Reduced Treg, Th17, and NK Cells
por: Więsik-Szewczyk, Ewa, et al.
Publicado: (2021) -
Shorter Diagnostic Delay in Polish Adult Patients With Common Variable Immunodeficiency and Symptom Onset After 1999
por: Ziętkiewicz, Marcin, et al.
Publicado: (2020)